中医药治疗对HIV/AIDS患者CD4计数变化的临床分析研究  被引量:6

A Clinical Study on the CD4 Count Changes of HIV/AIDS patients with Traditional Chinese Medical Treatment

在线阅读下载全文

作  者:杨绍春[1] 段呈玉[1] 赵竞[1] 王莉[1] 蔡怡[1] 孙俊[1] 方路[1] 马克坚[1] 

机构地区:[1]云南省中医中药研究院,云南昆明650223

出  处:《云南中医中药杂志》2011年第10期18-20,96,共3页Yunnan Journal of Traditional Chinese Medicine and Materia Medica

基  金:国家"十一五"科技重大专项综合示范项目"云南省防治艾滋病规模化现场流行病学和干预研究"(编号:2009ZX10004-902);国家"十一五"科技重大专项"无症状期HIV感染者中医药早期干预研究"(编号:2008ZX10005-002);中医药防治艾滋病;病毒性肝炎等疾病临床科研一体化技术平台体系构建及应用研究(编号:2009ZX10005-019)

摘  要:目的:观察康爱保生丸、扶正抗毒丸对HIV/AIDS患者不同疗程时的CD4细胞计数变化,并探讨纯中药治疗对HIV/AIDS患者的疗效。方法:给予HIV/AIDS患者康爱保生丸(组成:紫花地丁、黄芩、桑白皮、人参等)、扶正抗毒丸(组成:黄芪、黄精、白术、女贞子等)治疗,比较治疗前后CD4细胞计数变化。结果:对于CD4细胞计数小于350/mm3的患者,康爱保生丸、扶正抗毒丸提高其CD4细胞计数趋势明显;对于CD4细胞计数大于等于350/mm3的患者,康爱保生丸、扶正抗毒丸有减缓和逆转其CD4细胞计数下降趋势。结论:康爱保生丸、扶正抗毒丸对HIV/AIDS患者CD4细胞计数有提高或减缓和逆转其下降趋势的作用。Objective:To observe CD4 cell count changes of HIV/AIDS patients after different treatment courses with Kangaibaosheng pills and Fuzheng anti-drug pills and explore the effect of the two pills on the treatment of HIV/AIDS patients. Method:HIV/AIDS patients were treated with Kangaibaosheng pills (components:herba violae,scutearia,morus alba,ginseng,etc.),Fuzheng anti-drug pills (components:astragalus,solomonseal,atractylodes,ligustrum,etc.). The CD4 cell count changes were compared before and after the treatment. Results:For the patients with CD4 cell count less than 350/mm,Kangaibaosheng pills and Fuzheng anti-drug pills improved their CD4 cell count. For the patients with CD4 cell count greater than or equal 350/mm,Kangaibaosheng pills and Fuzheng anti-drug pills slowed down and reversed their CD4 cell count. Conclusion:Kangaibaosheng pills and Fuzheng anti-drug pills for HIV/AIDS patients with CD4 cell counts can increase,slow down or reverse the CD4 cell count of HIV/AIDS patients

关 键 词:艾滋病 康爱保生丸 扶正抗毒丸 CD4 

分 类 号:R512.91[医药卫生—内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象